Regulation of eosinophil recruitment and allergic airway inflammation by tropomyosin receptor kinase A

Mythili Dileepan, Xiao Na Ge, Idil Bastan, Yana G. Greenberg, Yuying Liang, P. Sriramarao, Savita P. Rao

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Eosinophilia is a hallmark of allergic airway inflammation (AAI). Identifying key molecules and specific signaling pathways that regulate eosinophilic inflammation is critical for development of novel therapeutics. Tropomycin receptor kinase A (TrkA) is the high-affinity receptor for nerve growth factor. AAI is associated with increased expression of TrkA by eosinophils; however, the functional role of TrkA in regulating eosinophil recruitment and contributing to AAI is poorly understood. This study identifies, to our knowledge, a novel mechanism of eotaxin-mediated activation of TrkA and its role in regulating eosinophil recruitment by using a chemical-genetic approach to specifically inhibit TrkA kinase activity with 1-NM-PP1 in TrkAF592A-knock-in (TrkA-KI) eosinophils. Blockade of TrkA by 1-NM-PP1 enhanced eosinophil spreading on VCAM-1 but inhibited eotaxin-1 (CCL11)- mediated eosinophil migration, calcium flux, cell polarization, and ERK1/2 activation, suggesting that TrkA is an important player in the signaling pathway activated by eotaxin-1 during eosinophil migration. Further, blockade of matrix metalloprotease with BB-94 inhibited eotaxin-1-induced TrkA activation and eosinophil migration, additively with 1-NM-PP1, indicating a role for matrix metalloproteases in TrkA activation. TrkA inhibition in Alternaria alternata-challenged TrkA-KI mice markedly inhibited eosinophilia and attenuated various features of AAI. These findings are indicative of a distinctive eotaxin-mediated TrkAdependent signaling pathway, which, in addition to other TrkA-activating mediators, contributes to eosinophil recruitment during AAI and suggests that targeting the TrkA signaling pathway to inhibit eosinophil recruitment may serve as a therapeutic strategy for management of eosinophilic inflammation in allergic airway disease, including asthma.

Original languageEnglish (US)
Pages (from-to)682-693
Number of pages12
JournalJournal of Immunology
Volume204
Issue number3
DOIs
StatePublished - Feb 1 2020

Bibliographical note

Funding Information:
This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases Grant AI137487 (to S.P.R.).

Fingerprint

Dive into the research topics of 'Regulation of eosinophil recruitment and allergic airway inflammation by tropomyosin receptor kinase A'. Together they form a unique fingerprint.

Cite this